Despite Flat Budget, NIH’s TRND Program Tries to Spark Interest in Rare and Neglected Diseases
With 14 approved programs in total, TRND has progressed two into clinical development.
AVI Enters Into Collaborations for the Development of Products for DMD
Collaborations Represent Key Inflection Point in AVI's Progress in Developing Treatments for Broader DMD Population
Local family helps raise money for Duchenne MD
Local Family Helps Raise Money for Duchenne MD
Results of Prosensa’s Extended Phase I/II Exon-skipping Trial in Duchenne Muscular Dystrophy
Results of Prosensa’s Extended Phase I/II Exon-skipping Trial in Duchenne Muscular Dystrophy
Department of Defense Duchenne Muscular Dystrophy Research Program
Department of Defense Duchenne Muscular Dystrophy Research Program
First Treatment for Muscular Dystrophy in Sight
First Treatment for Muscular Dystrophy in Sight: Scientists Harness Exon-Skipping in Large Animal to Successfully Treat Duchenne Muscular Dystrophy
Congress Appropriates Duchenne Muscular Dystrophy Translational Research Funding Through the Department of Defense
Congress Appropriates Duchenne Muscular Dystrophy Translational Research Funding Through the Department of Defense.
Promising Dystrophy Drug Clears Early Test
Promising Dystrophy Drug Clears Early Test
http://www.nytimes.com/2007/12/27/health/27drug.html?_r=1&fta=y&oref=slogin
FED announces financial support for the first international workshop
FED announces financial support for the first international workshop on pre-clinical methods in mouse drug screening trials in the muscular dystrophies.
